SCHEMBL17878477

SCHEMBL17878477

Brc1cc(Br)cc(-c2ccc(N(c3ccccc3)c3ccc4ccccc4c3)cc2)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 1/20 0.41
ESR1 P03372 3/20 0.37
ESR2 Q92731 3/20 0.37
ALDH1A1 P00352 5/20 0.36
CYP1A2 P05177 3/20 0.36
KDM4E B2RXH2 2/20 0.36
CYP2C9 P11712 2/20 0.36
CYP2C19 P33261 2/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
MAPT P10636 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
MAPK1 P28482 1/20 0.35
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
TP53 P04637 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
HSD17B10 Q99714 1/20 0.34
ACMSD Q8TDX5 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17878470 1.00 CYP2A6 (0.41) CYP2A6ESR1ESR2ALDH1A1CYP1A2
SCHEMBL17878498 0.95 CYP2A6 (0.40) CYP2A6ESR1ESR2ALDH1A1CYP1A2
SCHEMBL17878500 0.92 ESR1 (0.42) ESR1ESR2ALDH1A1CYP1A2KDM4E
SCHEMBL17878475 0.92 ALDH1A1 (0.37) CYP2A6ESR1ESR2ALDH1A1CYP1A2
SCHEMBL14849850 0.90 CYP2A6 (0.48) CYP2A6ESR1ESR2ALDH1A1CYP1A2
SCHEMBL29992507 0.90 CYP2A6 (0.48) CYP2A6ESR1ESR2ALDH1A1CYP1A2
SCHEMBL17878492 0.89 CYP2A6 (0.38) CYP2A6ESR1ESR2ALDH1A1CYP1A2
SCHEMBL18090366 0.89 CYP2A6 (0.40) CYP2A6ESR1ESR2ALDH1A1CYP1A2
SCHEMBL17878469 0.88 CYP2A6 (0.45) CYP2A6ALDH1A1CYP1A2KDM4ECYP2C9
SCHEMBL7047750 0.88 ESR1 (0.42) CYP2A6ESR1ESR2ALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9957441-B2 Amine-based compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2018-05-01 US disclosed
US-20160190464-A1 AMINE-BASED COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2016-06-30 US disclosed
US-20160190464-A1 AMINE-BASED COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2016-06-30 US disclosed
US-20160190467-A1 AMINE-BASED COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2016-06-30 US disclosed
US-20160190467-A1 AMINE-BASED COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2016-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160190467-A1 AMINE-BASED COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME AOC2, TYR, TAAR1 CYP2A6 1331/4885ESR1 56/4885ESR2 458/4885
US-20160190464-A1 AMINE-BASED COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME AOC2, TYR, TAAR1 CYP2A6 1484/4885ESR1 64/4885ESR2 563/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.